MM-102 trifluoroacetate

CAS No. ——

MM-102 trifluoroacetate( —— )

Catalog No. M17058 CAS No. ——

A high-affinity, small-molecule peptidomimetic inhibitor of MLL1/WDR5 protein-protein interaction with Ki of 2.4 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MM-102 trifluoroacetate
  • Note
    Research use only, not for human use.
  • Brief Description
    A high-affinity, small-molecule peptidomimetic inhibitor of MLL1/WDR5 protein-protein interaction with Ki of 2.4 nM.
  • Description
    A high-affinity, small-molecule peptidomimetic inhibitor of MLL1/WDR5 protein-protein interaction with Ki of 2.4 nM; effectively decreases the expression of HoxA9 and Meis-1; specifically inhibits cell growth and induces apoptosis in leukemia cells harboring MLL1 fusion proteins.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    HMTase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    783.8282
  • Molecular Formula
    C37H50F5N7O6
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    ——
  • Chemical Name
    (S)-N-(bis(4-fluorophenyl)methyl)-1-(2-(2-ethyl-2-isobutyramidobutanamido)-5-guanidinopentanamido)cyclopentanecarboxamide 2,2,2-trifluoroacetate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Karatas H, et al. J Am Chem Soc. 2013 Jan 16;135(2):669-82.
molnova catalog
related products
  • GSK3326595

    A potent, selective, reversible and orally active PRMT5 inhibitor with IC50 of 22 nM.

  • UNC0638

    A potent, selective, substrate-competitive inhibitor of G9a (EHMT2) and GLP (EHMT1) with IC50 of <15 nM and 19 nM in SAHH-coupled assays, respectively.

  • MI-463

    MI-463 is a highly potent and orally bioavailable small-molecule inhibitor of menin–MLL.